CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGY

EUIPO EUIPO 2022 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGY was filed as Figurative mark on 08/05/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/10/2022. The current status of the mark is "Trademark registered".

Logodesign (Wiener Klassifikation)

#One arrow #Arrows combined with any other figurative element (except A 24.15.13 and A 24.15.15) #Pin icons #Backgrounds, in words or numerals, divided into two, three or four #Letters surmounted by a sign of disproportionate size #Red, pink, orange #Blue #Grey

Trademark Details Last update: February 14, 2023

Trademark form Figurative mark
File reference 018742540
Application date August 5, 2022
Publication date September 2, 2022
Entry date December 10, 2022
Expiration date August 5, 2032

Trademark owner

475 Green Oaks Parkway
27540 Holly Springs
US

Trademark representatives

Claude Debussylaan 54 1082 MD Amsterdam NL

goods and services

42 Conducting clinical trials for pharmaceutical preparations; conducting clinical trials for flu vaccines; providing information about the results of clinical trials for flu vaccines; providing medical and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development
44 Pharmaceutical and medical information

ID: 11018742540